Navigation Links
Amylin Pharmaceuticals Reports Third Quarter Financial Results
Date:10/19/2011

uarter ended September 30, 2011 from $70.0 million for the same period in 2010. The decrease primarily reflects lower expenses associated with BYDUREON pre-launch activities and a reduced cost structure associated with the Company's efforts to drive efficiencies in the business.  

Research and development expenses decreased to $46.6 million for the quarter ended September 30, 2011 from $51.2 million for the same period in 2010. The decrease reflects reduced spending for BYDUREON pre-launch inventory manufacturing, partially offset by increased spending on our metreleptin development program.  

Collaborative profit sharing, which represents Lilly's share of the gross margin for BYETTA, was $59.0 million for the quarter ended September 30, 2011, compared to $61.2 million for the same period in 2010.

Non-GAAP operating income was $13.0 million for the quarter ended September 30, 2011 compared to a non-GAAP operating loss of $16.1 million for the same period in 2010. Net loss excluding restructuring charges was $10.7 million, or $0.07 per share, for the quarter ended September 30, 2011, an improvement of 76% compared to $44.7 million, or $0.31 per share, for the same period in 2010. GAAP net loss was $13.2 million, or $0.09 per share, for the quarter ended September 30, 2011, compared to a GAAP net loss of $50.7 million, or $0.35 per share, for the same period in 2010.

Nine Months Ended September 30, 2011Total revenues for the nine months ended September 30, 2011 were $485.7 million. This includes net product sales of $460.7 million, including $385.1 million for BYETTA and $75.6 million for SYMLIN. This compares to net product sales of $488.8 million, consisting of $422.9 million for BYETTA and $65.9 million for SYMLIN for the same period in 2010.

Revenues under collaborative agreements were $25.0 million for the nine months ended September 30, 2011, and included a $15.0 million milestone payment from Lilly in connection
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amylin Pharmaceuticals to Webcast Third Quarter Results
2. Amylin Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
3. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
4. Amylin Pharmaceuticals to Webcast Second Quarter Results
5. U.S. District Court Rules in Favor of Lilly in Amylin Litigation
6. Amylin Pharmaceuticals Issues Statement Regarding U.S. District Court Order
7. Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly
8. Lilly Comments on Court Ruling in Amylin Litigation
9. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
10. Lilly Provides Its Perspective in Response to Amylin Lawsuit
11. Lilly Provides Statement in Response to Amylin Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... BOSTON , Sept. 16, 2014 QPID ... a move to new headquarters in Boston ... The new headquarters will be at 175 Franklin Street in ... operations and marketing teams. QPID Health,s new Southern ... Parkway in Carlsbad.  The expansion will help meet the demands ...
(Date:9/16/2014)... , Sept. 16, 2014  Decision Resources Group finds that the ... billion in 2013 to over $18.2 billion in 2023 in ... Germany , Italy , ... and Japan . TNF-alpha inhibitors will remain the ... RA market, but growth will be constrained and patient shares will ...
(Date:9/16/2014)... 2014  Formex, LLC ("Formex"), a leader in ... Weilersbacher joined Formex as Director of Quality ... Greg Weilersbacher has over 20 ... in Quality Assurance, Facility Validation, GMP manufacturing, and ... to Formex a diverse wealth of experience. ...
Breaking Medicine Technology:QPID Health Announces Major Office Expansion in Boston and Opens Facility in San Diego 2The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 2The Rheumatoid Arthritis Drug Market Will Grow to $18.2 Billion in 2023, Driven by the Uptake of Oral Jak Inhibitors and Non TNF-alpha Biologics 3Greg Weilersbacher Joins Formex, LLC As Director of Quality Assurance and Quality Control 2
(Date:9/16/2014)... September 16, 2014 Who:, The Pulmonary ... Medical Campus and Children’s Hospital Colorado are ... the country’s leading pulmonary hypertension association that works to find ... disease of the lungs that affects the functioning of the ... mean survivability is only 2.8 years. , What:, Colorado ...
(Date:9/16/2014)... September 16, 2014 As part of ... Latin American Citizens (LULAC) will host the second annual ... Salud will feature free health screenings for osteoporosis, HIV, ... includes glucose and cholesterol levels as well as bone ... for children under 6 years old , The event ...
(Date:9/16/2014)... 16, 2014 (HealthDay News) -- Including women older than ... to a sharp reduction in advanced forms of the ... breast cancer screening programs could result in older women ... So, the decision to screen older women for breast ... recommended. "Instead of using mass screening, the decision ...
(Date:9/16/2014)... HealthDay Reporter TUESDAY, Sept. ... cancer survivors are alive today, compared to just 3 ... reported Tuesday. These individuals amount to 4 percent ... childhood cancer, according to the association,s annual progress report. ... treatment of cancer and details some of the challenges ...
(Date:9/16/2014)... for Radiation Oncology (ASTRO) has selected C.M. Charlie Ma, ... Oncology, and Director of Medical Physics at Fox ... The distinguished members selected to receive the Fellow of ... on Tuesday, September 16, at the ASTRO,s 56th Annual ... Fellows designation is a great honor and we are ...
Breaking Medicine News(10 mins):Health News:Help Fight Pulmonary Hypertension at the Colorado PH in the Park 2014 2Health News:LULAC Hosts Second Annual Latinos Living Healthy Feria de Salud in Los Angeles 2Health News:Some Benefits of Screening Elderly Women for Breast Cancer Questioned 2Health News:Targeted Drugs Among Successes Against Cancer, Says New Report 2Health News:Targeted Drugs Among Successes Against Cancer, Says New Report 3Health News:Targeted Drugs Among Successes Against Cancer, Says New Report 4
... A new UC Irvine study finds that lithium chloride, ... the development of inclusion body myositis, a skeletal muscle ... by scientists Frank LaFerla and Masashi Kitazawa, mice genetically ... six months after receiving daily doses of lithium chloride, ...
... Go,Healthcare, Inc. (OTC Bulletin Board: OGOH; ,OTG, ,the ... integrator,announced today that after more than four industry ... Value Added Reseller (,VAR,),business unit to Tampa, FL ... of the sale, in the amount of $4 ...
... to scenic attractions, COLUMBIA, S.C., March 18 ... Costa Rica for care now have a convenient ... farms, biological reserves,and other breathtaking scenery while awaiting ... division of Columbia, S.C.-based Companion,Global Healthcare Inc., has ...
... study appearing in the March 2008 issue of the ... natural family planning method developed by researchers from Georgetown ... women to family planning. More than half the women ... used family planning and on average, contraceptive use increased ...
... DALLAS, March 18 Phoenix Health Systems, a ... on the,business goals of healthcare organizations, announced today ... Management Services, Inc.,(TMSI) has awarded Phoenix Health Systems, ... TMSI performs considerable due diligence to,make certain the ...
... N.J., March 18 Barr,Pharmaceuticals, Inc. (NYSE: ... (LSE: PLVD), sent Notice to Deutsche Bank, acting ... Deposit Agreement (the "Deposit,Agreement") effective June 19, 2008 ... PLIVA will seek to delist from the London,Stock ...
Cached Medicine News:Health News:Lithium chloride slows onset of skeletal muscle disorder 2Health News:Lithium chloride slows onset of skeletal muscle disorder 3Health News:On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group 2Health News:On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group 3Health News:On The Go Healthcare Sells VAR Business to Wireless and Internet Space Development Leader FTS Group 4Health News:Companion Global Dental Clients Have New Reason to Smile in Costa Rica 2Health News:New choices bring wider range of women to family planning 2Health News:Texas Organization of Rural and Community Hospitals (TORCH) Awards Phoenix Health Systems Endorsed Vendor Status 2Health News:Barr's PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange 2Health News:Barr's PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange 3Health News:Barr's PLIVA Subsidiary to Terminate GDR Deposit Agreement and Delist From London Stock Exchange 4
Ungrooved permanent silicone strip. Indications: For trapdoor procedure. Overall length: 125 mm, 4.9 inches....
Ungrooved permanent silicone strip. Indications: For trapdoor procedure. Overall length: 125 mm, 4.9 inches....
Used with Double Tantalum Clip (250 style) E5381 852. Overall length: 7.0 mm....
Concave inner surface to conform to the globe. Indications: Wide scleral bed. Outside diameter 32 mm....
Medicine Products: